智通财经APP讯,昊海生物科技(06826)公布,经总经理提名,公司提名委员会审核通过,董事会同意续聘王文斌先生、张军东先生为公司副总经理,任期均为三年,自本次董事会审议通过之日起计算。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.